1、Conclusion the human hepatic portal vein system possibly is close related with the Chong Vessel.
結(jié)論：人體肝門靜脈系可能與經(jīng)絡(luò)沖脈密切相關(guān)。

2、Overall mean recipient portal vein flow was much higher than the left PVF in the donors.
總體平均受體門靜脈血流量較供體門脈左支血流量要高得多。

3、Anastomosed donor's and recipient's portal vein end to end.
供肝門靜脈與受體門靜脈端端吻合。

4、The abnormal expression of E-cadherin significantly was related with portal vein embolus or not(P
鈣粘素異常表達(dá)在門靜脈有無癌栓中呈明顯相關(guān)（P

5、Of or relating to the portal vein or the portal system.
門靜脈門靜脈的，門靜脈系統(tǒng)的，與門靜脈系統(tǒng)有關(guān)的

6、Experimental Study on Catheterized Chemotherapy in Portal Vein System
門靜脈系統(tǒng)插管化療的實(shí)驗(yàn)研究

7、Conclusion the portal vein occlusion may reduce the VEGF expression of hepatic VX2 tumor.
結(jié)論門靜脈阻斷可使兔肝VX2移植瘤的VEGF表達(dá)減弱。

8、The levels of TF and CP were not obviously different between peripheral and portal vein blood.
外周血血清轉(zhuǎn)鐵蛋白和銅藍(lán)蛋白與門靜脈血比較無顯著性差異（P>0.05）。

9、Objective To evaluate the effect of portal vein arterialization on hepatic regeneration.
目的探討門靜脈動脈化重建肝血流后對肝臟再生的影響。

10、The portal vein hemodynamic changes were observed by color Doppler ultrasound.
彩色多普勒檢測門靜脈系統(tǒng)血流動力學(xué)指標(biāo)。

11、Hepatic artery thrombosis and portal vein thrombosis were observed in one case each.
發(fā)生肝動脈血栓形成和發(fā)生門靜脈血栓形成的患者各發(fā)現(xiàn)一例。

12、Venopathy of the portal vein was common and associated with splenomegaly.
門靜脈病變普遍存在(80%)并且與脾大相關(guān)。

13、Double chemoembolization of hepatic carcinoma by TACE and portal vein PCS
TACE聯(lián)合經(jīng)門靜脈PCS雙重化療栓塞治療肝癌

portal vein翻譯